Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
HHS-OIG Drops Potential Action Against Howard Solomon
On August 5, 2011, the Office of Inspector General for the Department of Health and Human Services dropped a potential…
Successful patent litigation jury verdict for VNUS Medical
Davis Polk represented VNUS Medical in patent infringement litigation since 2005 in the Northern District of California…
Shareholder Plaintiff's Fee Petition in Roche-Ventana Merger Denied
On January 20, 2009, the Delaware Court of Chancery heard oral argument and denied a Ventana Medical Systems, Inc…